Filing status
- Accounts due
- 30 September 2027
- Last accounts
- 31 December 2025
- Conf. stmt due
- 31 December 2026
- Last conf. stmt
- 17 December 2025
Amber Therapeutics Holdings Limited
- Incorporated
- 18 December 2020 (5 years)
- Previously known as
- Amber Therapeutics Ltd (until 11 July 2024)This list may be incomplete. See all names on Companies House
- Industry
- Research and experimental development on biotechnology (72110)
- Directors
- David Rogers AmersonCaroline ButlerYen-Min Kevin Chu
- Accounts type
- Group
- Region
- South East
- Address
- Unit 1 Tech Foundry 2Curie AvenueDidcotOX11 0QQ
Officers 6 active
Officer details are public data from the Companies House register.
Amerson, David Rogers
Director · Appointed 15 April 2025
American
Born December 1962 (63)
Butler, Caroline
Director · Appointed 23 May 2024
Irish
Born February 1980 (46)
Chu, Yen-Min Kevin
Director · Appointed 23 May 2024
Canadian
Born February 1989 (37)
Le, Tiffany
Director · Appointed 23 May 2024
American
Born June 1990 (36)
British,Canadian
Born October 1986 (40)
Director · Appointed 18 December 2020
Also at Amber Therapeutics Limited
British
Born October 1983 (43)
Officer history (2 former)
15 April 2025
Appointed Amerson, David Rogers as Director
23 May 2024
Appointed Butler, Caroline as Director
23 May 2024
Appointed Chu, Yen-Min Kevin as Director
23 May 2024
Appointed Le, Tiffany as Director
23 May 2024
30 April 2024
1 December 2023
18 June 2021
18 June 2021
18 December 2020
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Corporate entity · Notified 28 May 2025
Owns 25–50% of shares
Holds 25–50% of voting rights
Company Limited By Shares
Reg. no. 16279473
Holdings 2
Companies where Amber Therapeutics Holdings Limited is registered as a person with significant control
Owns 75–100% of shares
Active
Owns 75–100% of shares
Dissolved
Former controllers (2)
28 May 2025
Ceased Oxford Science Enterprises PLC — Owns 25–50% of shares
18 June 2021
Financials
Figures from 2024 accounts. Newer accounts, made up to 31 December 2025, are filed but not read yet. See them on Companies House
- Net Assets
- £21,207,007
- Cash
- £164,652
- Profit
- (£2,659,202)
- Debt Ratio
- 0%
- Current Ratio
- 14101.5x
- Return on Equity
- -13%
Trend
Net Assets
Balance sheet detail
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Fixed Assets | £3,750,578 | £3,284,958 | ||
| Current Assets | £17,457,667 | £2,913,209 | £200,330 | £502,723 |
| Debtors | £5,660 | £4,039 | ||
| Cash | £164,652 | £2,295,352 | £194,670 | £498,684 |
| Creditors (< 1 year) | £1,238 | £7,219,574 | £6,255 | £5,608 |
| Creditors (> 1 year) | £0 | £732,009 | ||
| Net Current Assets | £17,456,429 | (£4,306,365) | £194,075 | £497,115 |
| Net Assets | £21,207,007 | (£1,753,416) | £196,977 | £499,108 |
| Shareholder Funds | £21,207,007 | (£1,753,416) | £196,977 | £499,108 |
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 4 November 2026 | Statement of capital following an allotment of shares |
Some other companies at this address
Other companies in this industry
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →